Spero Therapeutics Cash from Operations (TTM) Trends

Spero Therapeutics Inc (SPRO)

1.50 -0.03 (-1.96%) USD | NASDAQ | Apr 16, 15:41

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2017. Upgrade now.

Date	Value
December 31, 2023	-33.00M
September 30, 2023	28.98M
June 30, 2023	12.11M
March 31, 2023	7.639M
December 31, 2022	-7.731M
September 30, 2022	-79.56M
June 30, 2022	-83.56M
March 31, 2022	-77.09M
December 31, 2021	-64.35M
September 30, 2021	-53.38M
June 30, 2021	-69.69M
March 31, 2021	-78.02M
December 31, 2020	-85.87M

Date	Value
September 30, 2020	-86.86M
June 30, 2020	-75.25M
March 31, 2020	-62.42M
December 31, 2019	-50.02M
September 30, 2019	-46.16M
June 30, 2019	-42.02M
March 31, 2019	-38.59M
December 31, 2018	-39.62M
September 30, 2018	-38.86M
June 30, 2018	-43.86M
March 31, 2018	-44.09M
December 31, 2017	-39.11M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

-86.86M

Minimum

Sep 2020

28.98M

Maximum

Sep 2023

-49.80M

Average

-62.42M

Median

Mar 2020

Cash from Operations (TTM) Benchmarks